Tailoring the targeted treatment of chronic lymphocytic leukemia

Bidragets beskrivning

The CLL-CLUE project will identify novel biomarkers and implement AI-based clinical decision support systems to guide personalized treatment decisions in CLL. We expect that this will lead to significantly increased treatment efficacy, individualization of therapy and reduced drug use and side effects. In addition, reduced consumption of drugs and cost-effective outcomes will lower financial stress that the health care providers and patients experience.
Visa mer

Startår

2021

Slutår

2025

Beviljade finansiering

Tero Aittokallio Orcid -palvelun logo
299 099 €

Finansiär

Finlands Akademi

Typ av finansiering

Kansainvälinen yhteisrahoitteinen ohjelma

Övriga uppgifter

Finansieringsbeslutets nummer

344698

Vetenskapsområden

Data- och informationsvetenskap

Forskningsområden

Laskennallinen tiede

Identifierade teman

cancer